Philip Morris Misr Announces Price Increase for its Cigarettes’ & Heated Tobacco Products
Philip Morris Misr announces new prices for all variants of its heated tobacco products ‘HEETS’ and conventional cigarettes ‘Merit, Marlboro and L&M’.
“The price increase comes as a necessity to continue securing our ability to provide Egyptian adult smokers and nicotine users with the premium quality products they seek” stated Ali N. Karaman, Egypt & Levant Managing Director.
Philip Morris Misr’s new price list is as follows:
All variants of Merit will be sold officially at EGP 64 per pack.
All variants of Marlboro will be sold officially at EGP 59 per pack.
All variants of Marlboro Crafted will be sold officially at EGP 49 per pack.
All variants of L&M will be sold officially at EGP 42 per pack.
All variants of HEETS Selections will be sold officially at EGP 50 per pack.
All variants of HEETS Dimensions will be sold officially at EGP 50 per pack.
PMM also confirms that the company is providing the market with its usual and full capacity of products through trade and retail partners at official pricing. The company calls on retail traders to adhere to the official price list announced by PMM.
The company added that the prices of its entire product portfolio is available through the QR Code that has been applied on both conventional cigarette and heated tobacco packs, and encourages consumers to scan the QR code to verify the official retail sales price, as well as access the price list for Philip Morris’s product portfolio in Egypt.
PMM confirms its compliance to transparency standards, stating that it will further announce any upcoming price increase, aiming to protect consumer rights by combating illegal market practices and supporting regulators in their price compliance efforts.
**
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat not-burn, vapor, and oral nicotine products. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration (FDA) has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products (MRTPs). As of December 31, 2022, PMI’s smoke-free products were available for sale in 73 markets, and PMI estimates that approximately 17.8 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 32% of PMI’s total full-year 2022 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma subsidiary, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com
